PFIZER CEO SAYS ORAL COVID DRUG COULD BE READY BY END OF THE YEAR

  • 28/04/2021

An oral drug for treating coronavirus could be ready next year, Pfizer CEO Albert Bourla said. Further, he added that the company is working for an oral as well as an injectable antiviral.He said the company is focusing more on the oral variant, as it can be administered by people themselves from their homes. Presently the only antiviral currently approved for use against the coronavirus is remdesivir, which is manufactured byGilead Sciences. The US Food and Drug Administration (FDA) gave the drug full approval in October after it was granted emergency use authorization in May last year.He also said the medication could be more effective against the multiple variants, as such is the condition around the world. He further reported that thus far, over 121 million doses of the vaccine have been administered across the United States.

Related News